CYTOMEGALOVIRUS INFECTIONS
Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to fight hidden virus in people with HIV
⭐️ VACCINE ⭐️ CompletedThis study tested a vaccine called Triplex® in 94 adults who have both HIV and cytomegalovirus (CMV). The goal was to see if the vaccine is safe and helps the immune system control CMV. Participants received two shots of the vaccine or a placebo over 4 weeks and were followed for…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
New CMV vaccine enters first human tests – could prevent dangerous infections
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tests a new vaccine against cytomegalovirus (CMV), a common virus that can cause serious problems in newborns and people with weakened immune systems. The study involves 339 healthy adults aged 18 to 50, who will receive different doses of the vaccine or a …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:10 UTC
-
New CMV vaccine candidate enters first human tests
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tests a new vaccine called SPYVLP01 designed to protect against cytomegalovirus (CMV), a common virus that can cause serious problems in newborns and people with weak immune systems. The study involves 120 healthy adults aged 18 to 50 and will check if the …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE1 • Sponsor: SpyBiotech Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
Could early CMV and TB drugs save HIV-Positive babies with pneumonia?
Disease control CompletedThis study tested whether giving HIV-infected infants with severe pneumonia early treatment for cytomegalovirus (CMV) and tuberculosis (TB) could help them survive. Over 500 babies aged 1 month to 1 year were randomly assigned to receive either standard care or additional drugs f…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE2, PHASE3 • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC
-
Supercharged immune cells take on viruses in transplant patients
Disease control CompletedThis study tested whether giving patients special immune cells (T cells) that target CMV or adenovirus could control these infections after a stem cell transplant. Sixteen children and adults received one or two doses of these cells. The goal was to reduce virus levels in the blo…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:25 UTC
-
Promising new test spots hidden virus after transplant
Diagnosis CompletedThis study tested a new blood test that looks for a tiny piece of the CMV virus's genetic material (a microRNA) in 60 patients who had a stem cell transplant. The goal was to see if this test could detect CMV reactivation earlier or more accurately than the standard DNA test. Res…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: Ting YANG • Aim: Diagnosis
Last updated Jun 26, 2026 17:32 UTC
-
Hidden immune fire: could CMV or autoimmunity be fueling HIV-Related inflammation?
Knowledge-focused CompletedThis study looks at why certain immune cells (CD4 and CD8 T cells) remain activated in people with HIV whose viral load has been undetectable on antiretroviral therapy for at least two years. Researchers are investigating whether a common virus called cytomegalovirus (CMV) or an …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Real-world check on new CMV drugs in transplant patients
Knowledge-focused CompletedThis study followed 400 stem cell transplant recipients to see how well anti-CMV medications work in everyday hospital care. Researchers tracked infections, drug resistance, and side effects. The goal was to gather real-life data to improve treatment guidelines for these high-ris…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC